The cost can reach upwards of $900 for just one months supply
2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
Yes, they target visceral fat effectively
Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions
By targeting both, Retatrutide offers a more comprehensive treatment strategy than drugs that target only one receptor
This regimen is intended to support metabolism, digestion, nutrient sufficiency and be an adjunct or alternative to jumping straight into GLP-1 medication